Cargando…
Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy
Cardiomyocyte death is a fundamental progress in cardiomyopathy. However, the mechanism of triggering the death of myocardial cells remains unclear. Ferroptosis, which is the nonapoptotic, iron-dependent, and peroxidation-driven programmed cell death pathway, that is abundant and readily accessible,...
Autores principales: | Zhai, Zhenyu, Zou, Pengtao, Liu, Fuxiang, Xia, Zirong, Li, Juxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047193/ https://www.ncbi.nlm.nih.gov/pubmed/33869204 http://dx.doi.org/10.3389/fcell.2021.649045 |
Ejemplares similares
-
Ferroptosis: A Novel Therapeutic Target for Ischemia-Reperfusion Injury
por: Chen, Yunqing, et al.
Publicado: (2021) -
Ferroptosis Related Genes in Ischemic and Idiopathic Cardiomyopathy: Screening for Potential Pharmacological Targets
por: Jiang, Yufeng, et al.
Publicado: (2022) -
Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease
por: Chen, Kai, et al.
Publicado: (2021) -
Targeting of CAT and VCAM1 as Novel Therapeutic Targets for DMD Cardiomyopathy
por: Li, Bin, et al.
Publicado: (2021) -
Macrophage, a potential targeted therapeutic immune cell for cardiomyopathy
por: Chen, Ganyi, et al.
Publicado: (2022)